The detection of chronic heart graft rejection by 31P NMR spectroscopy

Surgery Today

Volumn 29, Issue 2, 1999, Pages 143-148

  Suzuki, Kazuhiro ^a   Hamano, Kimikazu ^a   Ito, Hiroshi ^a   Fujimura, Yoshihiko ^a   Esato, Kensuke ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

31P nuclear magnetic resonance spectroscopy; Chronic rejection; Graft arteriosclerosis; Heart transplantation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; CYCLOSPORIN; PHOSPHATE;

ALLOGRAFT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; ISOGRAFT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; RAT;

EID: 0033018096     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02482239     Document Type: Article

References (23)

1. 1. Abbott CP, DeWitt CW, Creech O Jr (1965) The transplanted rat heart: histologic and electrocardiographic changes. Transplantation 3:432-445
2. 2. Keren A, Gillis AM, Freedman RA, Raldwin JC, Rillingham MF, Stinson FR, Simson MR, Mason JW (1984) Heart transplant rejection monitored by signal-averaged electrocardiography in patients receiving cyclosporine. Circulation 70 (Suppl 1):I-124-I-129
3. 3. Hansen DE, Daughters GT II, Alderman EL, Stinson EB, Baldwin JC, Miller DC (1987) Effect of acute human cardiac allograft rejection on left ventricular systolic torsion and diastolic recoil measured by intramyocardial markers. Circulation 76:998-1008
4. 4. Frist W, Yasuda T, Segall G, An Khaw B, Strauss HW, Gold H, Stinson E, Oyer P, Baldwin J, Billingham M, McDougall IR, Haber E (1987) Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging. Circulation 76 (Suppl V):V-81-V-85
5. 5. Mohanakumar T, Hoshinaga K, Wood NL, Szentpetry S, Lower RR (1986) Enumeration of transferrin-receptor-expressing lymphocytes as a potential marker for rejection in human cardiac transplant recipients. Transplantation 42:691-694
6. 6. Kawaguchi A, Goldman MH, Shapiro R, Foegh ML, Ramwell PW, Lower RR (1987) Urinary thromboxane excretion of cardiac allograft rejection in immunosuppressed rats. Transplantation 43:346-350
7. 7. Carrier M, Emery RW, Wild-Mobley J, Perrotta NJ, Russell DH, Copeland JG (1987) Prolactin as a marker of rejection in human heart transplantation. Transplant Proc 19:3442-3443
8. 8. Aherne T, Yee ES, Tscholakff D, Gollin G, Higgins C, Ebert PA (1988) Diagnosis of acute and chronic cardiac rejection by magnetic resonance imaging. A non-invasive in vivo study. J Cardiovasc Surg 29:587-590
9. 9. Aherne T, Tscholakff D, Finkbeiner W, Sechtem U, Derugin N, Yee E, Higgins CB (1986) Magnetic resonance imaging of cardiac transplants: the evaluation of rejection of cardiac allografts with and without immunosuppression. Circulation 74:145-156
10. 10. Revel D, Chapelon C, Mathieu D, Cochet P, Ninet J, Chuzel M, Champsaur G, Dureau G, Amiel M, Helenon O, Vasile N, Cachera JP, Loisance D (1989) Magnetic resonance imaging of human orthotopic heart transplantation: correlation with endomyocardial biopsy. J Heart Transplant 8:139-146
11. 11. Lund G, Morin RL, Olivari MT, Ring WS (1988) Serial myocardial T2 relaxation time measurements in normal subjects and heart transplant recipients. J Heart Transplant 7:274-279
12. 12. Canby RC, Evanochko WT, Barrett LV, Kirklin JK, McGiffin DC, Sakai TT, Brown ME, Foster RE, Reeves RC, Pohost GM (1987) Monitoring the bioenergetics of cardiac allograft rejection using in vivo p-31 nuclear magnetic resonance spectroscopy. J Am Coll Cardiol 9:1067-1074
13. 13. Haug CE, Shapiro JI, Chan L, Weil R III (1987) P-31 nuclear magnetic resonance spectroscopic evaluation of heterotopic cardiac allograft rejection in the rat. Transplantation 44:175-178
14. 14. Fraser CD Jr, Chacko VT, Jacobus WE, Soulen RL, Hutchins GM, Reitz BA, Baumgartner WA (1988) Metabolic changes preceding function and morphologic indices of rejection in heterotopic cardiac allografts. Transplantation 46:346-351
15. 15. Fraser CD Jr, Chacko VP, Jacobus WE, Mueller P, Soulen RL, Hutchins GM, Reitz BA, Baumgartner WA (1990) Early phosphorus 31 nuclear magnetic resonance bioenergetic changes potentially predict rejection in heterotopic cardiac allografts. J Heart Transplant 9:197-204
16. 16. Walpoth BH, Tschopp A, Lazeyras F, Galdikas J, Tschudi J, Altermatt H, Schaffner T, Aue WP, Althaus U (1993) Magnetic resonance spectroscopy for assessing myocardial rejection in the transplanted rat heart. J Heart Lung Transplant 12:271-282
17. 17. Walpoth BH, Galdikas J, Tschopp A, Vorburger T, Lazeyras F, Schaffner T, Althaus U (1991) Differentiation of cardiac ischemia and rejection by nuclear magnetic spectroscopy. Thorac Cardiovasc Surgeon 39:217-220
18. 18. Liebert M, Kunz HW, Gill TJ, Cramer DV (1982) CML Characterization of a product of a second class I locus in the rat MHC. Immunogenetics 16:143
19. 19. Rao VK, Lisitza M (1985) Accessory heart transplantation to groin in the rat. A new model for retransplantation experiments. Transplantation 40:567-569
20. 20. Billingham ME, Cary NRB, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Transplant 9:587-593
21. 31P nuclear magnetic resonance spectroscopy and left ventricular function in underperfused guinea-pig hearts. J Mol Cell Cardiol 18:149-155
22. 22. Flaherty JT, Weisfeldt ML, Bulkley BH, Gardner TJ, Gott VL, Jacobus WE (1982) Mechanisms of ischemic myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance. Circulation 65:561-571
23. 23. Adams DH, Tilney NL, Collins JJ, Karnovsky MJ (1992) Experimental graft arteriosclerosis. Transplantation 53:1115-1119